Literature DB >> 14565235

Phosphono peptide nucleic acids with a constrained hydroxyproline-based backbone.

Vladimir A Efimov1, Valeryi N Klykov, Oksana G Chakhmakhcheva.   

Abstract

DNA mimics representing negatively charged analogues of peptide nucleic acids (PNAs), particularly hetero-oligomers constructed from alternating phosphono-PNA residues (pPNA) and monomers on the base of trans-4-hydroxy-L-proline (HypNA) as well as mimics composed of phosphono-HypNA monomers (pHypNA) were tested in a set of in vitro and in vivo assays, and they demonstrated a high potential for the use in nucleic acid based diagnostic, isolation of nucleic acids and antisense experiments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565235     DOI: 10.1081/NCN-120021962

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids.

Authors:  Kevin T Duffy; Mary Frances McAleer; William R Davidson; Laszlo Kari; Csaba Kari; Chang-Gong Liu; Steven A Farber; Keith C Cheng; Jason R Mest; Eric Wickstrom; Adam P Dicker; Ulrich Rodeck
Journal:  Nucleic Acids Res       Date:  2005-09-02       Impact factor: 16.971

2.  Hydroxyproline-based DNA mimics provide an efficient gene silencing in vitro and in vivo.

Authors:  Vladimir A Efimov; Klara R Birikh; Dmitri B Staroverov; Sergei A Lukyanov; Maria B Tereshina; Andrey G Zaraisky; Oksana G Chakhmakhcheva
Journal:  Nucleic Acids Res       Date:  2006-05-02       Impact factor: 16.971

3.  Polyanionic Carboxyethyl Peptide Nucleic Acids (ce-PNAs): Synthesis and DNA Binding.

Authors:  Yuliya Kirillova; Nataliya Boyarskaya; Andrey Dezhenkov; Mariya Tankevich; Ivan Prokhorov; Anna Varizhuk; Sergei Eremin; Dmitry Esipov; Igor Smirnov; Galina Pozmogova
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.